Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC42H46ClF2N9O7S |
InChIKeyZZAMCOWPQNSLBF-CPIPLPSASA-N |
CAS Registry2489876-41-5 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Discovery | United States | 23 Jun 2020 |





